ASX miners set for tough start even as commodity premiums hit a 14-year high
Brendon Lau | May 3, 2021 9:52am |
More on: Image source: Getty Images
ASX mining shares could be under pressure this morning even though price premiums paid for commodities have risen to the highest since 2007.
The
BHP Group Ltd(ASX: BHP) share price and
Rio Tinto Limited(ASX: RIO) will be watched closely as their US and UK-listed shares lost ground on the weekend.
If these shares underperform the
Fortescue Metals Group Limited(ASX: FMG) share price or other ASX miners.
Commodity price premiums hit a high
The sombre Monday morning outlook for the sector stands in contrast to the commodities futures market.
UK-listed firms issued 50 statements telling investors their profits would be lower than expected
Profit warnings from companies fell by the largest amount on record in the first three months of this year, according to EY.
UK-listed firms issued 50 statements telling investors their profits would be lower than expected, down 83 per cent from the 301 over the same period of 2020, the accountancy giant said.
But the lack of warnings ‘disguises the challenging outlook for UK businesses’, EY’s management consulting arm EY-Parthenon cautioned.
Its head of restructuring Alan Hudson said: ‘For many businesses, pressures will intensify as they restart operations, government support tapers, and working capital is stretched.’
But for a brief window every year, shareholders are given the tools to gain control. Over the next few weeks, most UK-listed companies will be holding their AGMs and an annual vote.
But for a brief window every year, shareholders are given the tools to gain control.
Over the next few weeks, most UK-listed companies will be holding their annual general meetings and an annual vote. Here, every shareholder from the biggest pension fund to the smallest individual investor has a right to have their voice heard.
Have your say: AGMs are open to all investors and even if you have just one single share, you are entitled to vote
AGMs are open to all investors and even if you have just one single share, you are entitled to vote.
Anyone can stand up and ask a question of the board or the chief executive. It s a right well worth using to help shape the companies you are relying on to grow your long-term wealth.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU AS IT FORMS PART OF LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.
Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for deadly blood diseases, announces its results for the year ended 31 December 2020.
• Demonstrated that HEMO-CAR-T cells are effective against Acute Myloid Leukemia in vitro and in vivo • Developed a novel cell-based platform technology, referred to as CBR, for the treatment of emerging viral diseases, including COVID-19, as well as certain types of cancer